Solriamfetol (Sunosi), a selective dopamine and norepinephrine reuptake inhibitor, improved sleepiness compared with placebo ...
In " Beyond Diagnosis: Breast Cancer," Cleveland Clinic oncologist Tiffany Onger, MD, and host John Mangels continue their ...
Three drugs that inhibit the immunoglobulin G (IgG) neonatal fragment crystallizable receptor (FcRn) were approved to treat ...
Rheumatoid arthritis (RA) patients face increased risk for interstitial lung disease (ILD) that is worsened further by the ...
The word "influenza" originally stemmed from the medieval Latin influentia at a time when fluids emanating from heavenly ...
Every day, we seem to be inundated with more and more innovations and new technologies, whizbang cool devices, software, and blood tests. It's getting easier and easier to test and detect more and ...
The FDA has approved the topical phosphodiesterase 4 (PDE4) inhibitor difamilast (Adquey) as a new option for mild/moderate atopic dermatitis (AD).
As I type this, I am fighting back my own tears. Our reality is heartbreaking. But my tears are also filled with something else: frustration. Frustration that once again, medicine and science seem to ...
Now, CMS' Innovation Center, which created Making Care Primary, is set to launch a new 10-year program to boost primary care called the Long-term Enhanced ACO Design, known by its acronym LEAD. In ...
An injured seabird sought help by pecking at the door of an emergency room at a hospital in Germany until medical staff noticed it and called firefighters to help with its rescue. The cormorant, a ...
Patients with low-risk HPV had greater rates of orbital decompression surgery (13.4% vs 5.5%; risk ratio 2.46, 95% CI 1.25-4.81, P =0.006) versus those without HPV, but rates of corticosteroid use, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results